脊髓刺激市场规模、份额、成长分析、按适应症、按产品、按最终用户、按地区 - 产业预测，2024-2031 年

2022年全球脊髓刺激市场规模为29亿美元，从2023年的31.3亿美元成长到2031年的57亿美元，复合年增长率预计为7.8%。

脊髓刺激设备(SCS)，也称为背柱刺激器，作为治疗慢性疼痛的有效神经调节剂，已在全球市场上获得广泛认可。这种植入式装置可以阻断疼痛讯号，帮助患有脊椎、背部和四肢疼痛的人们，特别是在传统药物和治疗无效的情况下。除了最近的技术进步外，有关 SCS 手术的新法律指南和对微创治疗的日益偏好正在进一步推动市场成长。久坐生活方式引起的慢性疼痛的增加也导致对神经刺激疗法的需求激增。由于这些因素的结合，SCS市场可能会在不久的将来经历指数级增长并享受更大的机会。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

脊髓刺激市场规模：依适应症及复合年增长率（2024-2031）

• 市场概况
• 脊椎手术失败症候群
• 复杂性局部疼痛综合症
• 退化性椎间盘疾病
• 其他的

脊髓刺激市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 可充电装置
• 不可充电设备

脊髓刺激市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院
• 门诊手术中心
• 其他的

脊髓刺激疗法市场规模与复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Nevro Corp.（USA）
• Stimwave Technologies, Inc.（USA）
• Saluda Medical Pty Ltd.（Australia）
• Synapse Biomedical Inc.（USA）
• Cirtec Medical（USA）
• Nalu Medical, Inc.（USA）
• Beijing PINS Medical Co., Ltd.（China）
• Gimer Medical（China）
• BIOTRONIK SE & Co. KG（Germany）
• St. Jude Medical, Inc.（acquired by Abbott）（USA）
• NeuroSigma, Inc.（USA）
• Greatbatch, Inc.（USA）
• Curonix LLC（USA）
• Teliatry, Inc.（USA）
• Spinal Modulation（USA）
• NevroSpin（USA）
• Axonics Modulation Technologies, Inc.（USA）

结论和建议

Global Spinal Cord Stimulation Market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.13 billion in 2023 to USD 5.7 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2024-2031).

The spinal cord stimulator (SCS), also known as the dorsal column stimulator, is gaining significant traction in the global market as an effective neuromodulation device for chronic pain management. This implanted tool disrupts pain signals, aiding individuals suffering from spinal, back, or limb pain, particularly when traditional medications and therapies fail. Recent advancements in technology, alongside new legislative guidelines for SCS operations and the rising preference for minimally invasive treatments, have further fueled market growth. The increasing prevalence of chronic pain, largely attributable to sedentary lifestyles, is also contributing to the surging demand for neurostimulation therapies. This combination of factors positions the SCS market for expansive growth and greater opportunities in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spinal Cord Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spinal Cord Stimulation Market Segmental Analysis

Global Spinal Cord Stimulation Market is segmented by indication, product, end user and region. Based on indication, the market is segmented into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease and others. Based on product, the market is segmented into rechargeable devices and non-rechargeable devices. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spinal Cord Stimulation Market

The Global Spinal Cord Stimulation market is being propelled forward by continuous technological advancements and supportive government recommendations. Manufacturers are focusing on research to produce smaller spinal cord stimulators, exemplified by Stimwave LCC's Freedom SCS system, which is about 5% smaller than current Implantable Pulse Generators (IPGs). This reduction in size, along with improvements in impulse generation, significantly contributes to the market's growth. Furthermore, various government associations are developing guidelines for spinal cord stimulation therapy to treat chronic pain and other conditions. Notably, the National Institute for Health and Care Excellence has provided recommendations for the Senza SCS system, which delivers HF10 therapy for neuropathic pain, fostering increased market activity through these favorable endorsements.

Restraints in the Global Spinal Cord Stimulation Market

The Global Spinal Cord Stimulation market faces several significant restraints that impede its growth. One of the primary challenges is the high cost associated with spinal cord stimulator implantation, which ranges from $21,000 to $58,000. The financial burden varies depending on the patient's insurance status, whether private or public, or if they are paying out-of-pocket. Moreover, ongoing maintenance expenses-including hardware costs, salaries of healthcare providers, pulse generator replacements, and hospitalization fees-add to the overall financial strain on patients. Additionally, the limited availability of healthcare equipment in remote areas restricts access to treatment, forcing local populations to depend on larger towns for essential medical services.

Market Trends of the Global Spinal Cord Stimulation Market

The Global Spinal Cord Stimulation (SCS) market is experiencing a significant upward trend due to increasing government initiatives aimed at reducing opioid dependence. With rising concerns about opioid misuse, alternative therapies that provide effective pain management without the addictive risks of opioids are gaining traction. This shift has prompted manufacturers such as Medtronic, Abbott, and Boston Scientific to expedite the development and approval of innovative SCS devices, evidenced by over 200 submissions to the FDA for rapid approval. As awareness and demand for these non-opioid solutions continue to rise, the SCS market is poised for substantial growth, presenting lucrative opportunities for stakeholders.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Spinal Cord Stimulation Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

Global Spinal Cord Stimulation Market Size by Product & CAGR (2024-2031)

• Market Overview
• Rechargeable Devices
• Non-Rechargeable Devices

Global Spinal Cord Stimulation Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Spinal Cord Stimulation Market Size & CAGR (2024-2031)

• North America (Indication, Product, End User)
  • US
  • Canada
• Europe (Indication, Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cirtec Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nalu Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gimer Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (acquired by Abbott) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greatbatch, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curonix LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teliatry, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spinal Modulation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NevroSpin (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations